This is the authors' abstract. We don't add key points for this paper.
The incidence and the endemic range of Lyme disease in the United States have increased steadily since the disease was originally recognized in Lyme, Connecticut, in 1975. Because of the varied clinical manifestations of this illness and the use of unstandardized serologic testing methods, diagnosis is often uncertain and treatment outcomes are often difficult to evaluate. The antibiotic regimens that are commonly used in clinical practice have changed rapidly. They show much regional variation with little critical comparison of treatment results. The clinical diagnosis and the literature on the treatment of the various stages of Lyme disease are reviewed. The reported data are supplemented with recommendations based on 15 years of clinical experience with this illness.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Rahn et al. (1991) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: